Aflibercept exhibits VEGF binding stoichiometry distinct from bevacizumab and does not support formation of immune-like complexes

Overview of attention for article published in Angiogenesis, May 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter: 3 X users

patent: 1 patent

Citations

dimensions_citation: 30 Dimensions

Readers on

mendeley: 61 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Antibody inhibiting binding of VEGF to NRP1

Grant US-11008387-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.